SEC Form 4 · accession 0001209191-19-007770
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul M Silva
Officer — SVP & Interim CFO
Period of report
Feb 4, 2019
Accepted (ET)
Feb 6, 2019 · 4:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 4, 2019 | M | 809 | $86.52 | A | 16,896 | D | |
| Common Stock | Feb 4, 2019 | S | 809 | $189.19 | D | 16,087 | D | |
| Common StockF2,F3 | Feb 4, 2019 | S | 600 | $185.11 | D | 15,487 | D | |
| Common StockF3,F4 | Feb 4, 2019 | S | 450 | $186.17 | D | 15,037 | D | |
| Common StockF3,F5 | Feb 4, 2019 | S | 2,268 | $186.85 | D | 12,769 | D | |
| Common StockF3,F6 | Feb 4, 2019 | S | 120 | $188.33 | D | 12,649 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F7 | $86.52 | Feb 4, 2019 | M | 809 | D | — | Feb 2, 2027 | Common Stock | 809 | 6,472 | D |
Explanation of responses
- F1Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
- F2Open market sales reported on this line occurred at a weighted average price of $185.11 (range $184.54 to $185.49).
- F3Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- F4Open market sales reported on this line occurred at a weighted average price of $186.17 (range $185.74 to $186.52).
- F5Open market sales reported on this line occurred at a weighted average price of $186.85 (range $186.62 to $187.33).
- F6Open market sales reported on this line occurred at a weighted average price of $188.33 (range $188.25 to $188.35).
- F7The option vests in 16 quarterly installments from 02/03/2017.